Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 15, 2018
Cutaneous mucormycosisJean-Baptiste Vulsteke, Dries DeerenRheumatology International|May 23, 2026
Diffuse splenic calcifications in systemic lupus erythematosus: a case-based reviewCeline Tack, Ann Stuer, Jean-Baptiste VulstekeJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 6, 2019
Can We Expect Any Effect of Rituximab on Fatigue in Primary Sjögren Syndrome?: A Systematic Review and Critical AppraisalAn-Marie Hermans, Jean-Baptiste Vulsteke, Jan Lenaerts, et al.Acta Clinica Belgica|September 27, 2018
Rituximab in systemic autoimmune rheumatic diseases: indications and practical useNathalie Berghen, Jean-Baptiste Vulsteke, Rene Westhovens, et al.Clinical Rheumatology|November 12, 2019
The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic reviewWouter Schutyser, Ludovic Cruyt, Jean-Baptiste Vulsteke, et al.Clinical Rheumatology|May 23, 2019
Physical therapy in adult inflammatory myopathy patients: a systematic reviewAnna Van Thillo, Jean-Baptiste Vulsteke, Dieter Van Assche, et al.Autoimmunity Reviews|May 7, 2019
Anti-OJ autoantibodies: Rare or underdetected?Jean-Baptiste Vulsteke, Minoru Satoh, Kishore Malyavantham, et al.Clinical Chemistry and Laboratory Medicine|November 29, 2022
Anti-Ki/anti-PA28γ autoantibodies contribute to the HEp-2 indirect immunofluorescence nuclear speckled patternLise Boon, Thibaut Belmondo, Jean-Baptiste Vulsteke, et al.Rheumatology (Oxford, England)|December 29, 2019
Anti-TIF1-γ autoantibodies: warning lights of a tumour autoantigenJulie De Vooght, Jean-Baptiste Vulsteke, Petra De Haes, et al.Rheumatology International|April 30, 2025
Anti-TIF1-beta autoantibody-positive dermatomyositis: a case-based reviewJean-Baptiste Vulsteke, Petra De Haes, Minoru Satoh, et al.Pageof 3